In summary, the combined analysis of these case-control studies indicated that -160A of the E-cadherin gene is a tumor susceptibility allele for the development of urothelial and prostate cancers; however, this conclusion is based on unadjusted results, and more studies are needed. Here, CDH1 is linked to neoplasm.